Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Musumeci

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Molecular Medicine Reports|October 18, 2017
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809Barbara Marengo, Andrea Speciale, Lisa Senatore, et al.
Pharmaceutics|December 23, 2023
New Insights into the LANCL2-<b>ABA</b> Binding Mode towards the Evaluation of New LANCL AgonistsNaomi Scarano, Francesco Di Palma, Nicola Origlia, et al.
International Journal of Pharmaceutics|July 27, 2025
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatmentFederica Poggialini, Enrico Rango, Chiara Vagaggini, et al.
Organic & Biomolecular Chemistry|March 11, 2011
Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivityTiziano Tuccinardi, Alessandra Tania Zizzari, Chiara Brullo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl InhibitorsGiulia Vignaroli, Claudio Zamperini, Elena Dreassi, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 30, 2017
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme CellsGiada Catalogna, Cristina Talarico, Vincenzo Dattilo, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Water Solubility Enhancement of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives via Miniaturized Polymer-Drug MicroarraysMonica Sanna, Giovanna Sicilia, Ali Alazzo, et al.
Fluids and Barriers of the CNS|August 18, 2023
Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical modelsAlexandra Hochstetler, Hillary Smith, Makenna Reed, et al.
Pharmaceutics|February 25, 2023
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma MultiformeFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Molecular Medicine Reports|October 18, 2017
Matrine in association with FD‑2 stimulates F508del‑cystic fibrosis transmembrane conductance regulator activity in the presence of corrector VX809Barbara Marengo, Andrea Speciale, Lisa Senatore, et al.
Pharmaceutics|December 23, 2023
New Insights into the LANCL2-<b>ABA</b> Binding Mode towards the Evaluation of New LANCL AgonistsNaomi Scarano, Francesco Di Palma, Nicola Origlia, et al.
International Journal of Pharmaceutics|July 27, 2025
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatmentFederica Poggialini, Enrico Rango, Chiara Vagaggini, et al.
Organic & Biomolecular Chemistry|March 11, 2011
Substituted pyrazolo[3,4-b]pyridines as human A1 adenosine antagonists: developments in understanding the receptor stereoselectivityTiziano Tuccinardi, Alessandra Tania Zizzari, Chiara Brullo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl InhibitorsGiulia Vignaroli, Claudio Zamperini, Elena Dreassi, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 30, 2017
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme CellsGiada Catalogna, Cristina Talarico, Vincenzo Dattilo, et al.
ACS Medicinal Chemistry Letters|March 16, 2018
Water Solubility Enhancement of Pyrazolo[3,4-<i>d</i>]pyrimidine Derivatives via Miniaturized Polymer-Drug MicroarraysMonica Sanna, Giovanna Sicilia, Ali Alazzo, et al.
Fluids and Barriers of the CNS|August 18, 2023
Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical modelsAlexandra Hochstetler, Hillary Smith, Makenna Reed, et al.
Pharmaceutics|February 25, 2023
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma MultiformeFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Pageof 6